55 jobs found in cranbury township

Description: Job DescriptionThis position will work diligently to meet scheduled timelines, and will work overtime as required to meet production schedule. Weekend, holiday and shift work may be required based on manufacturing schedule as determined by Area Management. This position will report directly to the Clinical Manufacturing Team Lead with responsibilities including (but not limited to): A. Process Operations (60%) Performance of cGMP Operations in accordance with Standard Operating Procedures (SOP’s); Master Batch Records(MBR’s); Equipment Qualification Protocols; and other applicable instructional documentation. Inclusive of: i.Shipping, Receiving, Raw Material Release and Inventory Managementii.Weigh, Dispense and Solution Preparationiii.Upstream and Downstream Manufacturing Operations Communicates status of operations, process issues, and safety & maintenance issues to Area Management immediately.Provides initial review of executed documentation for completeness and...

Wuxi Biologics Requisition ID: 1622 Location: Cranbury, NJ Overview: Responsible for providing direct oversight, coaching, mentoring and leadership in the manufacture of biologics products performing activities within production facilities to support manufacture of upstream/ downstream operations according to current Good Manufacturing Practices (cGMPs). Essential Job Functions: Understands, oversees, trains, coaches, mentors and manages performance of others on basic aseptic operational techniques as well as, performing solution, material preparation, cell culture, and purification along with analyzing results and facility start-up engineering and mechanical knowledge Reviews and approves manufacturing SOPs/ protocols, executed manufacturing documentation/ results and resolves issues Identifies and drives application of GMP concepts and is able to recommend and identify improvements as the process develops during phases of technical transfer Identifies process and...

W.B. Mason Company, Inc. Equal Opportunity Employer W.B. Mason Company, Inc. is an Equal Opportunity Employer. Qualified applicants will receive consideration for employment without regard to race, color, religion, sex, national origin, sexual orientation, gender identity, disability or protected veteran status. Loader US-NJ-Cranbury Job ID: 2021-3937 Type: Full Time # of Openings: 1 Category: Distribution/Transportation/Warehouse Brunswick Overview The loader will help process and receive store orders to load trucks for morning delivery. Responsibilities Essential Duties and Responsibilities Assemble customer orders from stock and place orders on pallets. Load trucks for morning delivery. Manage work production so trucks are ready to go out on time and in good order. Keep communication and information updated to minimize disruption. Other duties as assigned. Knowledge, Skills and Abilities Must have a current and valid driver’s...

Wuxi Biologics Requisition ID: 1751 Location: Cranbury, NJ Job Summary: The senior buyer will work closely with the Worcester site end user team and collaborate with internal stakeholders to lead all local procurement activities. The person will evaluate the requirements, source the appropriate vendors, negotiate the contract, manage the cost and quality improvement, and assist the end user to make strategic sourcing decision. The person will be the local representative of WuXi Biologics Procurement in the North America, support the global strategic relationship establishment with key local vendors, and facilitate certain import/export activities. Essential Job Functions: Closely communicate with the end users to understand the requirements, analyze the RFQ, and ensure the site requirements are considered during the vendor sourcing Seek, identify, evaluate, and recommend the appropriate suppliers, execute sourcing and bidding strategies, and lead the...

Wuxi Biologics Requisition ID: 1800 Location: Cranbury, NJ Overview WuXi Biologics (stock code: 2269.HK), a Hong Kong-listed company, is a leading global open-access biologics technology platform offering end-to-end solutions to empower organizations to discover, develop and manufacture biologics from concept to commercial manufacturing. Our company history and achievements demonstrate our commitment to providing a truly ONE-stop service offering and strong value proposition to our global clients. As of December 31, 2018, there were a total of 205 integrated projects, including 97 projects in pre-clinical development stage, 94 projects in early-phase (phase I and II) clinical development, 13 projects in late-phase (phase III) development and 1 project in commercial manufacturing. With total estimated capacity of biopharmaceutical production planned in China, Ireland, Singapore and US reaching 220,000 liters by 2022, we will provide our bio manufacturing partners...

Wuxi Biologics Requisition ID: 1793 Location: Cranbury, NJ Overview WuXi Biologics (stock code: 2269.HK), a Hong Kong-listed company, is a leading global open-access biologics technology platform offering end-to-end solutions to empower organizations to discover, develop and manufacture biologics from concept to commercial manufacturing. Our company history and achievements demonstrate our commitment to providing a truly ONE-stop service offering and strong value proposition to our global clients. As of December 31, 2018, there were a total of 205 integrated projects, including 97 projects in pre-clinical development stage, 94 projects in early-phase (phase I and II) clinical development, 13 projects in late-phase (phase III) development and 1 project in commercial manufacturing. With total estimated capacity of biopharmaceutical production planned in China, Ireland, Singapore and US reaching 220,000 liters by 2022, we will provide our bio manufacturing partners...

Wuxi Biologics Requisition ID: 2155 Location: Cranbury, NJ Company Overview: WuXi Biologics (stock code: 2269.HK), a Hong Kong-listed company, is a leading global open-access biologics technology platform offering end-to-end solutions to empower organizations to discover, develop and manufacture biologics from concept to commercial manufacturing. Our company history and achievements demonstrate our commitment to providing a truly ONE-stop service offering and strong value proposition to our global clients. As of December 31, 2018, there were a total of 205 integrated projects, including 97 projects in pre-clinical development stage, 94 projects in early-phase (phase I and II) clinical development, 13 projects in late-phase (phase III) development and 1 project in commercial manufacturing. With total estimated capacity of biopharmaceutical production planned in China, Ireland, Singapore and US reaching 280,000 liters by 2022, we will provide our bio-manufacturing...

Wuxi Biologics Requisition ID: 1869 Location: Cranbury, NJ Company Overview: WuXi Biologics (stock code: 2269.HK), a Hong Kong-listed company, is a leading global open-access biologics technology platform offering end-to-end solutions to empower organizations to discover, develop and manufacture biologics from concept to commercial manufacturing. Our company history and achievements demonstrate our commitment to providing a truly ONE-stop service offering and strong value proposition to our global clients. As of December 31, 2018, there were a total of 205 integrated projects, including 97 projects in pre-clinical development stage, 94 projects in early-phase (phase I and II) clinical development, 13 projects in late-phase (phase III) development and 1 project in commercial manufacturing. With total estimated capacity of biopharmaceutical production planned in China, Ireland, Singapore and US reaching 280,000 liters by 2022, we will provide our biomanufacturing...

Wuxi Biologics Requisition ID: 1872 Location: Cranbury, NJ Company Overview: WuXi Biologics (stock code: 2269.HK), a Hong Kong-listed company, is a leading global open-access biologics technology platform offering end-to-end solutions to empower organizations to discover, develop and manufacture biologics from concept to commercial manufacturing. Our company history and achievements demonstrate our commitment to providing a truly ONE-stop service offering and strong value proposition to our global clients. As of December 31, 2018, there were a total of 205 integrated projects, including 97 projects in pre-clinical development stage, 94 projects in early-phase (phase I and II) clinical development, 13 projects in late-phase (phase III) development and 1 project in commercial manufacturing. With total estimated capacity of biopharmaceutical production planned in China, Ireland, Singapore and US reaching 280,000 liters by 2022, we will provide our biomanufacturing...

Wuxi Biologics Requisition ID: 1791 Location: Cranbury, NJ Company Overview: WuXi Biologics (stock code: 2269.HK), a Hong Kong-listed company, is a leading global open access biologics technology platform offering end-to-end solutions to empower organizations to discover, develop and manufacture biologics from concept to commercial manufacturing. Our company history and achievements demonstrate our commitment to providing a truly ONE-stop service offering and strong value proposition to our global clients. As of December 31, 2018, there were a total of 205 integrated projects, including 97 projects in pre-clinical development stage, 94 projects in early-phase (phase I and II) clinical development, 13 projects in late-phase (phase III) development and 1 project in commercial manufacturing. With total estimated capacity of biopharmaceutical production planned in China, Ireland, Singapore and US reaching 280,000 liters by 2022, we will provide our bio-manufacturing...

Wuxi Biologics Requisition ID: 1797 Location: Cranbury, NJ Overview WuXi Biologics (stock code: 2269.HK), a Hong Kong-listed company, is a leading global open-access biologics technology platform offering end-to-end solutions to empower organizations to discover, develop and manufacture biologics from concept to commercial manufacturing. Our company history and achievements demonstrate our commitment to providing a truly ONE-stop service offering and strong value proposition to our global clients. As of December 31, 2018, there were a total of 205 integrated projects, including 97 projects in pre-clinical development stage, 94 projects in early-phase (phase I and II) clinical development, 13 projects in late-phase (phase III) development and 1 project in commercial manufacturing. With total estimated capacity of biopharmaceutical production planned in China, Ireland, Singapore and US reaching 220,000 liters by 2022, we will provide our bio manufacturing partners...

Wuxi Biologics Requisition ID: 1849 Location: Cranbury, NJ Company Overview: WuXi Biologics (stock code: 2269.HK), a Hong Kong-listed company, is a leading global open-access biologics technology platform offering end-to-end solutions to empower organizations to discover, develop and manufacture biologics from concept to commercial manufacturing. Our company history and achievements demonstrate our commitment to providing a truly ONE-stop service offering and strong value proposition to our global clients. As of December 31, 2018, there were a total of 205 integrated projects, including 97 projects in pre-clinical development stage, 94 projects in early-phase (phase I and II) clinical development, 13 projects in late-phase (phase III) development and 1 project in commercial manufacturing. With total estimated capacity of biopharmaceutical production planned in China, Ireland, Singapore and US reaching 220,000 liters by 2022, we will provide our biomanufacturing...

Wuxi Biologics Requisition ID: 1792 Location: Cranbury, NJ Overview WuXi Biologics (stock code: 2269.HK), a Hong Kong-listed company, is a leading global open-access biologics technology platform offering end-to-end solutions to empower organizations to discover, develop and manufacture biologics from concept to commercial manufacturing. Our company history and achievements demonstrate our commitment to providing a truly ONE-stop service offering and strong value proposition to our global clients. As of December 31, 2018, there were a total of 205 integrated projects, including 97 projects in pre-clinical development stage, 94 projects in early-phase (phase I and II) clinical development, 13 projects in late-phase (phase III) development and 1 project in commercial manufacturing. With total estimated capacity of biopharmaceutical production planned in China, Ireland, Singapore and US reaching 220,000 liters by 2022, we will provide our bio manufacturing partners...

Wuxi Biologics Requisition ID: 1867 Location: Cranbury, NJ Company Overview: WuXi Biologics (stock code: 2269.HK), a Hong Kong-listed company, is a leading global open-access biologics technology platform offering end-to-end solutions to empower organizations to discover, develop and manufacture biologics from concept to commercial manufacturing. Our company history and achievements demonstrate our commitment to providing a truly ONE-stop service offering and strong value proposition to our global clients. As of December 31, 2018, there were a total of 205 integrated projects, including 97 projects in pre-clinical development stage, 94 projects in early-phase (phase I and II) clinical development, 13 projects in late-phase (phase III) development and 1 project in commercial manufacturing. With total estimated capacity of biopharmaceutical production planned in China, Ireland, Singapore and US reaching 280,000 liters by 2022, we will provide our biomanufacturing...

Wuxi Biologics Requisition ID: 1871 Location: Cranbury, NJ Company Overview: WuXi Biologics (stock code: 2269.HK), a Hong Kong-listed company, is a leading global open-access biologics technology platform offering end-to-end solutions to empower organizations to discover, develop and manufacture biologics from concept to commercial manufacturing. Our company history and achievements demonstrate our commitment to providing a truly ONE-stop service offering and strong value proposition to our global clients. As of December 31, 2018, there were a total of 205 integrated projects, including 97 projects in pre-clinical development stage, 94 projects in early-phase (phase I and II) clinical development, 13 projects in late-phase (phase III) development and 1 project in commercial manufacturing. With total estimated capacity of biopharmaceutical production planned in China, Ireland, Singapore and US reaching 280,000 liters by 2022, we will provide our biomanufacturing...

Wuxi Biologics Requisition ID: 1750 Location: Cranbury, NJ Company Overview: WuXi Biologics (stock code: 2269.HK), a Hong Kong-listed company, is a leading global open access biologics technology platform offering end-to-end solutions to empower organizations to discover, develop and manufacture biologics from concept to commercial manufacturing. Our company history and achievements demonstrate our commitment to providing a truly ONE-stop service offering and strong value proposition to our global clients. As of December 31, 2018, there were a total of 205 integrated projects, including 97 projects in pre-clinical development stage, 94 projects in early-phase (phase I and II) clinical development, 13 projects in late-phase (phase III) development and 1 project in commercial manufacturing. With total estimated capacity of biopharmaceutical production planned in China, Ireland, Singapore and US reaching 280,000 liters by 2022, we will provide our bio-manufacturing...

Wuxi Biologics Requisition ID: 1790 Location: Cranbury, NJ Overview WuXi Biologics (stock code: 2269.HK), a Hong Kong-listed company, is a leading global open-access biologics technology platform offering end-to-end solutions to empower organizations to discover, develop and manufacture biologics from concept to commercial manufacturing. Our company history and achievements demonstrate our commitment to providing a truly ONE-stop service offering and strong value proposition to our global clients. As of December 31, 2018, there were a total of 205 integrated projects, including 97 projects in pre-clinical development stage, 94 projects in early-phase (phase I and II) clinical development, 13 projects in late-phase (phase III) development and 1 project in commercial manufacturing. With total estimated capacity of biopharmaceutical production planned in China, Ireland, Singapore and US reaching 220,000 liters by 2022, we will provide our bio manufacturing partners...

Wuxi Biologics Requisition ID: 2090 Location: Cranbury, NJ Job Summary The QC Testing Scientist is responsible for the quality and on-time delivery of test results, validation data and other QC deliverables to internal and external clients. Demonstrates strong oral and written communication skills and actively contributes to training, report generation and documentation. Job Functions Conduct assays and lab procedures according to and in compliance with cGMP guidelines and internal SOPs Ensure that all analytical data from the laboratory is accurate, precise, robust and is generated by following methods, specifications and procedures Ensure compliance to training, testing, documentation and general lab maintenance requirements for Industry Standards and/or Regulations Prepares SOP, protocols, final reports, investigations, and deviations as needed Investigate any Out-of-Specification results and laboratory deviations, conduct root cause...

Wuxi Biologics Requisition ID: 1780 Location: Cranbury, NJ Overview WuXi Biologics (stock code: 2269.HK), a Hong Kong-listed company, is a leading global open-access biologics technology platform offering end-to-end solutions to empower organizations to discover, develop and manufacture biologics from concept to commercial manufacturing. Our company history and achievements demonstrate our commitment to providing a truly ONE-stop service offering and strong value proposition to our global clients. As of December 31, 2018, there were a total of 205 integrated projects, including 97 projects in pre-clinical development stage, 94 projects in early-phase (phase I and II) clinical development, 13 projects in late-phase (phase III) development and 1 project in commercial manufacturing. With total estimated capacity of biopharmaceutical production planned in China, Ireland, Singapore and US reaching 220,000 liters by 2022, we will provide our bio manufacturing partners...

Wuxi Biologics Requisition ID: 2091 Location: Cranbury, NJ Job Summary The Process Engineer in Global Engineering is to provide expert technical support to commercial biological manufacturing, development and analytical facilities and their design, build and C&Q. As a process engineer in global engineering, he/she also is a project engineer and project lead throughout the capital project cycle from project concept to GMP operation ready. It is essential for job success to have the ability to apply technical knowledge to create engineering solutions with regards to the bioprocessing equipment, and to conduct effective communication internally and externally to ensure the alignment of process engineering approaches with project / process requirements, regulatory strategies and the industry best practices. Essential Job Functions Assist/lead in design, build, and C&Q of manufacturing facilities, utilities and process of biopharmaceutical therapeutics....